This segment focuses on the development, manufacturing, and sales of reagents and automatic biochemistry analyzers used in clinical laboratories. Research and development efforts are directed towards improving the accuracy, efficiency, and automation of biochemical testing. Technologies employed include spectrophotometry, enzymatic assays, and immunoassay techniques. These products are crucial for diagnosing and monitoring a wide range of diseases, including liver and kidney disorders, diabetes, and cardiovascular diseases. BSBE's market positioning in this segment is strengthened by its focus on quality and innovation, addressing the growing demand for reliable and efficient diagnostic solutions in healthcare settings. Future opportunities include expanding the range of tests offered and integrating advanced data analytics for improved clinical decision-making.

This segment specializes in the development and production of reagents and automated coagulation analyzers. Research efforts are focused on enhancing the sensitivity and specificity of coagulation assays, as well as improving the automation and throughput of coagulation testing. Technologies used include clot detection, chromogenic assays, and immunoturbidimetric methods. These products are essential for assessing blood clotting function and diagnosing bleeding disorders, thrombotic conditions, and monitoring anticoagulant therapy. BSBE's competitive advantage lies in its ability to provide comprehensive solutions for coagulation testing, addressing the needs of clinical laboratories and healthcare providers. Future growth potential includes expanding into new markets and developing innovative assays for emerging coagulation markers.

This segment is dedicated to the development and manufacturing of serology products, including blood type test cards and automated blood grouping analyzers. Research and development activities are centered on improving the accuracy, speed, and ease of use of blood typing and antibody screening methods. Technologies employed include hemagglutination, gel microcolumn technology, and flow cytometry. These products are critical for ensuring safe blood transfusions and preventing hemolytic diseases in newborns. BSBE's market position in this segment is reinforced by its commitment to quality and regulatory compliance, meeting the stringent requirements of blood banks and transfusion services. Future opportunities include developing advanced assays for detecting rare blood types and improving the automation of blood grouping procedures.